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Abstract:  Seco-chaetomugilins A and D were isolated from a strain of Chaetomium 
globosum that was originally isolated from the marine fish Mugil cephalus, and their 
absolute stereostructures were elucidated on the basis of spectroscopic analyses, including 
1D and 2D NMR techniques, along with the chemical transformation from known 
chaetomugilins A and D. Seco-chaetomugilin D exhibited growth inhibitory activity 
against cultured P388, HL-60, L1210, and KB cells. 
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1. Introduction 
 
Marine microorganisms are potentially prolific sources of highly bioactive secondary metabolites 
that might serve as useful leads in the development of new pharmaceutical agents. Based on the fact 
that some of the bioactive materials isolated from marine animals have been produced by bacteria, we 
have focused our attention on new antitumor agents from microorganisms separated from marine 
organisms [1-5]. As part of this endeavor, we have conducted a search for antitumor compounds from 
a strain of Chaetomium globosum OUPS-T106B-6 that was originally isolated from the marine fish 
Mugil cephalus, and have reported six new cytotoxic metabolites designated as chaetomugilins A (1), 
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B, C, D (2), E, and F
 from the culture broth of this fungal strain [6,7]. These compounds are 
azaphilones and they display various bioactivities, including antimicrobial, nitric oxide inhibitory, 
gp120-CD4 binding inhibitory, monoamine oxidase inhibitory, and platelet-derived growth factor 
binding inhibitory properties [7].
 An examination of a disease-oriented panel of 39 human cancer cell 
lines (HCC panel) [8,9]
 suggested the possibility that the mode of action of chaetomugilins A (1), C, 
and F might be different from that shown by any other anticancer drugs developed to date [7]. Our 
continuing search for cytotoxic metabolites from this fungal strain yielded two new azaphilones 
designated as seco-chaetomugilins A (3) and D (4) (Figure 1). Seco-chaetomugilin D (4) exhibited 
significant cytotoxic activity against the murine P388 leukemia cell line, the human HL-60 leukemia 
cell line, the murine L1210 leukemia cell line, and the human KB epidermoid carcinoma cell line. We 
describe herein the absolute stereostructures and biological activities of these compounds. 
 
Figure 1. Structures of compounds 1-4. 
 
 
2. Results and Discussion  
 
C. globosum was cultured at 27 ºC for six weeks in a medium (100 L) containing 1% soluble starch 
and 0.1% casein in 50% artificial seawater adjusted to pH 7.4 as reported previously [6,7].
 After 
incubation, the AcOEt extract of the culture filtrate was purified by bioassay-directed fractionation 
(cytotoxicities against P388 cell line) employing a stepwise combination of Sephadex LH-20, silica gel 
column chromatography, and reversed-phase HPLC (RP-HPLC) to afford seco-chaetomugilins A (3) 
and D (4). 
Seco-chaetomugilin A (3) had the molecular formula C24H31ClO8, which was established from the 
[M+H]
+ ion in high-resolution fast atom bombardment mass spectrometry (HRFABMS) and the ratio 
of intensity of isotope ions (MH
+/[MH+2]
+). Its IR spectrum exhibited bands at 3,382, 1,736, and  
1,642 cm
-1, which are characteristic of hydroxyl, ester, and conjugated carbonyl groups, respectively. 
Close inspection of the 
1H- and 
13C-NMR spectra (Table 1) of 3 by DEPT and HMQC experiments 
revealed the presence of four secondary methyls (11-CH3, C-13, 4’-CH3, and C-6’), one tertiary 
methyl (7-CH3), one ester methyl (1’-OCH3), four sp
2-hybridized methines (C-1, C-4, C-9, and C-10) 
including oxygen-bearing carbon (C-1), six sp
3-methines (C-8, C-11, C-12, C-2’, C-4’ and C-5’) 
including two oxymethines (C-12 and C-5’), two quaternary oxygen-bearing sp
3-carbon (C-7 and   
C-3’) including a hemiketal carbon (C-3’), four quaternary sp
2-carbons (C-3, C-4a, C-5 and C-8a) 
including one oxygen-bearing carbon (C-3), and two carbonyls (C-6 and C-1’). 
1H-
1H COSY analysis 
of 3 revealed two partial structural units as shown by bold-faced lines in Figure 2. The geometrical Mar. Drugs 2009, 7                                                  
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configuration of the double bond moiety (Δ9, 10) was deduced to be trans from the coupling constants 
of the olefinic protons (J9,10 = 15.5 Hz). The connection of these units and the remaining functional 
groups was determined on the basis of the key HMBC correlations summarized in Figure 2. The 
connection of a chlorine atom to C-5 was reasonable from its chemical shift (δC 110.0). Thus, the 
planar structure of 3 was elucidated as shown in Figure 2. 
 
Figure 2. Selected 
1H-
1H COSY and HMBC correlations of compound 3. 
 
 
The relative stereochemistry of 3 was examined by conducting NOESY experiments. NOE 
correlations (8-H/4’-CH3 and 7-CH3/4’-CH3) implied that 8-H is oriented cis to the 7-methyl group 
and C-3’ – C-4’ bond. However, the relative configuration of C-11, C-12, C-2’, C-4’ and C-5’ could 
not be elucidated. Treatment with p-TsOH of chaetomugilin A (1) in MeOH gave chaetomugilins B 
and C as reported previously [6]. This time, the above reaction was carried out on the condition that 
more amount of p-TsOH was used, and then gave 3 together with chaetomugilins B and C (Scheme 1). 
Product 3 was confirmed to be identical to natural 3 on the basis of IR, UV, and NMR spectra and 
optical rotations. This result allowed us to assign the absolute configuration of all the asymmetric 
centers (7S, 8S, 11R, 12R, 2’R, 3’R, 4’R and 5’R) in 3. In order to confirm the absolute configuration 
of C-11 and C-12, alkaline degradation, which is used for the confirmation of flavone character, was 
applied to compound 3. The degradation of 3 with 5% potassium hydroxide afforded a carboxylic acid 
that was identified as (4R, 5R)-2E-5-hydroxy-4-methylhex-2-enoic acid by comparison of spectral data 
and specific optical rotation with those of carbonic acid obtained from 1 in a similar manner   
(Scheme 2) [10]. Thus, the absolute configuration at C-11 and C-12 of 3 were supported as R and R, 
respectively. 
 
Scheme 1. Chemical transformation from 1 and 2 to 3 and 4. 
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Scheme 2. Alkaline degradation of 3 and 4. 
 
 
Seco-chaetomugilin D (4), which contained one oxygen atom less than 3, was assigned the 
molecular formula C24H31ClO7 by HRFABMS. The general features of its UV, IR, and NMR spectra 
(Table 1) closely resembled those of 3 except that the proton signals for H-11 (δH 2.24, sept), H-12 
(δH 1.42, m), and H-13 (δH 0.89, t), and the carbon signals for C-10 (δC 146.2), C-11 (δC 38.8), C-12 
(δC 29.2), C-13 (δC 11.7), and 11-CH3 (δC 19.4) in 4 revealed a chemical shift difference relative to 
those of 3. The above evidence implied that the hydroxyl methine at C-12 in 3 was replaced with a 
methylene in 4. The planar structure of 4 was confirmed by analyzing 
1H-
1H COSY correlations and 
HMBC correlations. In NOESY experiments, the same NOE correlations (8-H/4’-CH3 and 7-CH3/4’-
CH3) as those of 3 were observed. As in compound 3, treatment with p-TsOH of 2 in MeOH gave 
product 4, which was confirmed to be identical to natural 4 on the basis of IR, UV, and NMR spectra 
and optical rotations. The above lines of evidence revealed the absolute stereostructure of 4. In order to 
confirm the absolute configuration of C-11, the alkaline degradation was applied to compound 4 by the 
above method. The degradation of 4 with 5% potassium hydroxide afforded a carboxylic acid that was 
identified as (S)-2E-4-methylhex-2-enoic acid by comparison of spectral data and specific optical 
rotation with those of a commercial sample (Scheme 2) [11]. Thus, the absolute configuration at C-11 
was supported as S.  
During the isolation process, the culture filtrate was extracted with AcOEt, and the time that 1 and 2 
were exposed to MeOH on LH-20 and the silica gel column chromatography was very short (6~7 h 
being the longest time). In addition, chaetomugilins A (1) and D (2) were stable in MeOH for a few 
days. As the above reaction, only compounds 3 and 4 were obtained in low yield by treatment with p-
TsOH of 1 and 2 in MeOH, respectively, but not obtained by the methanolysis using conc. H2SO4. 
These evidences confirm that seco-chaetomugilins A (3) and D (4) are not artifacts of 1 and 2, 
respectively. 
Assays for the growth inhibitory activity of other azaphilones using various cancer cell lines are 
rarely reported. As a primary screen for antitumor activities, the cancer cell growth inhibitory activities 
of 3 and 4 were examined using the murine P388 leukemia cell line, the human HL-60 leukemia cell 
line, the murine L1210 leukemia cell line, and the human KB epidermoid carcinoma cell line. 
Compound  4  exhibited moderate cytotoxicity to all cell lines (IC50: 38.6, 47.2, 53.6, 47.2 μM, 
respectively). On the other hand, compound 3 showed no growth inhibition against all cell lines. These 
results implied that the presence of the hydroxyl group at C-12 reduced the activity. 
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Table 1. 
1H- and 
13C-NMR data of compounds 3 and 4 in CDCl3. 
Position 
3 4 
δH
a  J/Hz  δC  δ H
a  J/Hz  δC  
1 
 
7.58  s  146.2 (d)  7.58 s  145.9 (d)
3 
 
156.6 (s)  157.1 (s) 
4 6.49  s 
 
105.1 (d)  6.46 s 
 
104.6 (d)
4a 
   
140.3 (s) 
 
140.5 (s) 
5 
 
110.0 (s)  109.7 (s) 
6  188.7 (s)  188.6 (s) 
7  83.1 (s)  83.1 (s) 
8  3.90  d  12.0 (2')  44.3  (d)  3.90  d  12.0 (2')  44.3  (d)
8a  114.7 (s)  114.6 (s) 
9  6.13  d  15.5 (10)  122.3  (d)  6.03  d  16.2 (10)  120.4  (d)
10 
 
6.58 dd 
15.5 (9), 7.8 
(11) 
141.6 (d)  6.48 dd 
16.2 (9), 
6.1 (11) 
146.2 (d)
11 
 
2.44 dqd 
7.8 (10), 6.5 
(11-CH3), 6.2 
(12) 
44.2 (d)  2.24 sept
6.1 (10, 12, 
11-CH3) 
38.8 (d)
12 
 
3.80  quint  6.2 (11, 13)  70.9  (d)  1.42  m 
 
29.2 
 
(t) 
13  1.19  d  6.2 (12)  20.4  (q)  0.89  t  7.2 (12)  11.7  (q)
7 -CH3  1.48  s  25.3 (q)  1.48 s  25.3 (q)
11 -CH3  1.12  d  6.5 (11)  14.9  (q)  1.07  d  6.1 (11)  19.4  (q)
1'  169.4 (s)  169.5 (s) 
2'  3.24  d  12.0 (8)  53.7  (d)  3.24  d  12.0 (8)  53.7  (d)
3'  107.5 (s)  107.5 (s) 
4' 
 
2.01 dq 
9.5 (5'), 6.8 (4'-
CH3) 
44.7 (d)  2.01 dq 
9.5 (5'), 6.5 
(4'-CH3) 
44.7 (d)
5' 
 
4.33  dq  9.5 (4'), 6.0 (6')  71.1  (d)  4.33  dq 
9.5 (4'), 6.1 
(6') 
71.1 (d)
6'  1.30  d  6.0 (5')  23.4  (q)  1.30  d  6.1 (5')  23.4  (q)
1' 
-
OCH3 
3.74 s 
 
52.1 (q)  3.74 s 
 
52.1 (q)
4' -CH3  0.83  d  6.8 (4')  13.3  (q)  0.83  d  6.5 (4')  13.2  (q)
3'  -OH  6.75  br s                         
 
3. Experimental 
 
General 
 
Melting points were determined on a Yanagimoto micro-melting point apparatus and are 
uncorrected. UV spectra were recorded on a Hitachi U-2000 spectrophotometer and IR spectra, on a 
JASCO FT/IR-680 Plus. NMR spectra were recorded at 27 ºC on Varian UNITY INOVA-500 and 
MERCURY spectrometers with tetramethylsilane (TMS) as internal reference. FABMS were obtained Mar. Drugs 2009, 7                                                  
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using a JEOL JMS-700 (Ver. 2) mass spectrometer. Optical rotations were recorded on a JASCO J-820 
polarimeter. Liquid chromatography over silica gel (mesh 230–400) was performed at medium 
pressure. HPLC was run on a Waters ALC-200 instrument equipped with a differential refractometer 
(R 401) and Shim-pack PREP-ODS (25 cm x 20 mm i. d.). Analytical TLC was performed on 
precoated Merck aluminum sheets (DC-Alufolien Kieselgel 60 F254, 0.2 mm) with the solvent system 
CH2Cl2-MeOH (9 : 1), and compounds were viewed under a UV lamp and sprayed with 10% H2SO4 
followed by heating. 
 
Culture and Isolation of Metabolites 
 
A strain of C. globosum was initially isolated from the marine fish M. cephalus collected in the 
Katsuura Bay of Japan in October 2000. The marine fish was wiped with EtOH and its gastrointestinal 
tract applied to the surface of nutrient agar layered in a Petri dish. Serial transfers of one of the 
resulting colonies provided a pure strain of C. globosum. The fungal strain was cultured at 27 ºC for 
six weeks in a liquid medium (100 L) containing 1% soluble starch and 0.1% casein in 50% artificial 
seawater adjusted to pH 7.4.
 The culture was filtered under suction and the mycelia collected were 
extracted thrice with MeOH. The combined extracts were evaporated in vacuo to give a mixture of 
crude metabolites (42.8 g), the CHCl3–MeOH (1:1) soluble fraction of which exhibited cytotoxicity. 
The culture filtrate was extracted thrice with AcOEt. The combined extracts were evaporated in vacuo 
to afford a mixture of crude metabolites (20.6 g). The AcOEt extract was passed through Sephadex 
LH-20 using CHCl3–MeOH (1:1) as eluent. The second fraction (7.2 g) in which the activity was 
concentrated was chromatographed on a silica gel column with a CHCl3–MeOH gradient as eluent. 
The CHCl3 eluate (1.5 g) was purified by HPLC using MeCN–H2O (4:1) as eluent to afford 4 (5.1 mg), 
and the MeOH–CHCl3 (1:99) eluate (1.8 g) was purified by HPLC using MeOH–H2O (1:1) as eluent 
to afford 3 (7.8 mg) together with other chaetomugilins, respectively.  
 
Seco-chaetomugilin A (3)  
 
Pale yellow powder; mp 97–99 °C (CHCl3–MeOH); [α]D
22 294.0 (c 0.09, EtOH); UV λmax (EtOH)/ 
nm: 292 (log ε 3.86), 373 (3.94), 405 (4.01); IR vmax (KBr)/cm
-1: 3,382 (OH), 1,736 (ester), 1,642 (α, 
β-unsaturated carbonyl), 1,563, 1,522 (C=C); FABMS m/z (rel. int.): 483 ([M+H]
+, 43.9%), 485 
([M+H+2]
+, 16.7%); HRFABMS m/z 483.1782 [M+H]
+ (calcd for C24H32
35ClO8 : 483.1785); 
1H- and 
13C-NMR data are listed in Table 1. 
 
Seco-chaetomugilin D (4)  
 
Pale yellow powder; mp 97–99°C (CHCl3–MeOH); [α]D
22 161.3 (c 0.13, EtOH); UV   
λmax (EtOH)/nm: 291 (log ε 3.88), 371 (3.80), 411 (3.88); IR vmax (KBr)/cm
-1: 3,431 (OH), 1,740 
(ester), 1,622 (α, β-unsaturated carbonyl), 1,564, 1,522 (C=C); FABMS m/z (rel. int.): 467 ([M+H]
+, 
65.1%), 469 ([M+H+2]
+, 23.2%); HRFABMS m/z 467.1840 [M+H]
+ (calcd for C24H32
35ClO7: 
467.1836); 
1H- and 
13C-NMR data are listed in Table 1. 
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Derivatization of 3 from 1  
 
p-TsOH (32.7 mg) was added to a MeOH solution (5 mL) of chaetomugilin A (1) (23.7 mg) and the 
reaction mixture was left at room temperature for 6 h. The solvent was evaporated under reduced 
pressure and the residue was purified by HPLC using MeCN–H2O (55:45) as eluent to afford 3  
(3.2 mg), chaetomugilin B (6.7 mg), and chaetomugilin C (5.5 mg). 
 
Degradation of 1 by Potassium Hydroxide 
 
Seco-chaetomugilin A (3, 15.2 mg) was dissolved in 5% aq. potassium hydroxide (10 mL) and the 
reaction mixture was stirred for 3 h at 100°C. Then, the reaction mixture was extracted with CHCl3  
(15 mL). The water layer was adjusted to pH 3.0 with 9% sulfuric acid and re-extracted with CHCl3 
(10 mL). The organic extract was concentrated to dryness in vacuo. The residue was purified by HPLC 
using MeCN–H2O gradient (0:100) – (60:40) as the eluent to afford (4R,5R)-2E-5-hydroxy-4-methyl-
hex-2-enoic acid (0.9 mg). Using the same procedure, chaetomugilin A (26.5 mg), the absolute 
stereostructure of which was determined already, was treated with 5% aq. potassium hydroxide   
(20 mL) and purified by HPLC to afford (4R,5R)-2E-5-hydroxy-4-methylhex-2-enoic acid (3.1 mg). 
Colorless oil; [α]D
22 90.0 (c 0.05, EtOH); HRFABMS m/z: 145.0867 [M+H]
+ (calcd for C7H13O3: 
145.0865); 
1H-NMR δ ppm (CDCl3): 1.12 (3H, d, J = 6.5 Hz, 4-CH3), 1.19 (3H, d, J = 6.2 Hz, H-6), 
2.44 (1H, dqd, J = 7.5, 6.5, 6.2 Hz, H-4), 3.80 (1H, quint, J = 6.2 Hz, H-5), 5.90 (1H, d, J = 15.5 Hz, 
H-2), 7.06 (1H, d, J = 15.5, 7.5 Hz, H-3). 
 
Derivatization of 4 from 2  
 
Using the same procedure as above with compound 2, chaetomugilin D (2) (22.8 mg) was treated 
with p-TsOH (27.7 mg) in MeOH (8 mL) and the products were purified by HPLC using MeCN–H2O 
(7:3) as eluent to afford 4 (3.5 mg), chaetomugilin E (8.6 mg), and chaetomugilin F (7.2 mg). 
 
Degradation of 2 by Potassium Hydroxide  
 
Seco-chaetomugilin D (4, 16.7 mg) was dissolved in 5% aq. potassium hydroxide (15 mL) and the 
reaction mixture was stirred for 3 h at 100°C. Then, the reaction mixture was extracted with CHCl3  
(15 mL). The water layer was adjusted to pH 3.0 with 9% sulfuric acid and re-extracted with 
petroleum ether (15 mL). The organic extract was concentrated to dryness in vacuo. The residue was 
purified by HPLC using MeCN–H2O gradient (0:100) – (100:0) as the eluent to afford (S)-2E-4-
methylhex-2-enoic acid (0.7 mg). The physicochemical properties of this carboxylic acid were 
identical with those of a commercial sample [10]. 
 
Assay for Cytotoxicity to the Cancer Cell Lines 
 
Cytotoxicity of seco-chaetomugilins A (3) and D (4) were examined by the 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) method. P388, HL-60, L1210, and KB cells Mar. Drugs 2009, 7                                                  
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were cultured in Eagle’s Minimum Essential Medium (10% fetal calf serum) at 37 ºC in 5% CO2. The 
test material was dissolved in dimethyl sulfoxideto give a concentration of 10 mM, and the solution 
was diluted with the Essential Medium to give concentrations of 200, 20, and 2 μM, respectively. Each 
solution was combined with each cell suspension (1 × 10
5 cells/mL) in the medium, respectively. After 
incubating at 37 ºC for 72 h in 5% CO2, grown cells were labeled with 5 mg/mL
 MTT in phosphate 
buffered saline (PBS), and the absorbance of formazan dissolved in 20% sodium dodecyl sulfate 
(SDS) in 0.1 N HCl was measured at 540 nm using a microplate reader (Model 450, BIO-RAD). Each 
absorbance value was expressed as percentage relative to the control cell suspension that was prepared 
without the test substance with the same procedure as that described above. All assays were performed 
three times. Semilogarithmic plots were constructed from the averaged data and the effective dose of 
the substance required to inhibit cell growth by 50% (IC50) was determined.  
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